Related references
Note: Only part of the references are listed.Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure
Emily C. Ayers et al.
CANCER (2020)
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
Babak Otoukesh et al.
CANCER CELL INTERNATIONAL (2020)
Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker
Andrew Siref et al.
LEUKEMIA RESEARCH (2020)
Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets
K. M. Taufiqul Arif et al.
CANCERS (2020)
Significance of the microRNA-17-92 gene cluster expressed in B-cell non-Hodgkin's lymphoma
Shujie Yan et al.
MOLECULAR MEDICINE REPORTS (2019)
miR-29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR-29 regulation
Luciano Mazzoccoli et al.
ONCOLOGY REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials
Jean-Marie Michot et al.
INVESTIGATIONAL NEW DRUGS (2018)
MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells
Luciano Mazzoccoli et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Management of relapsed/refractory DLBCL
Clementine Sarkozy et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2018)
TET2 coactivates gene expression through demethylation of enhancers
Lu Wang et al.
SCIENCE ADVANCES (2018)
Dysregulation of TET2 in hematologic malignancies
Shigeru Chiba
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression
Kinga Szurian et al.
LEUKEMIA RESEARCH (2017)
Integrated analysis of genome-wide gene expression and DNA methylation microarray of diffuse large B-cell lymphoma with TET mutations
Pengfei Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance
Drirh Khare et al.
PLOS ONE (2017)
miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential
Carla Sole et al.
CANCER LETTERS (2017)
MicroRNAs as novel targets and tools in cancer therapy
Mohammed L. Abba et al.
CANCER LETTERS (2017)
Of mice and men: correlations between microRNA-17∼92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia
Mary E. Robbins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis
Marcela Cristina Robaina et al.
ANNALS OF HEMATOLOGY (2016)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma
Alejandro Roisman et al.
GENES CHROMOSOMES & CANCER (2016)
Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma
Gabrielle Bradshaw et al.
GENES (2016)
MicroRNAs-from metastasis prediction to metastasis prevention?
Mohammed Abba et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
Michele Dal Bo et al.
Oncotarget (2015)
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
Nicola Amodio et al.
ONCOTARGET (2015)
Genetic Variants in MiRNA Processing Genes and Pre-MiRNAs Are Associated with the Risk of Chronic Lymphocytic Leukemia
Idoia Martin-Guerrero et al.
PLOS ONE (2015)
Genetic and epigenetic variants in the MTHFR gene are not associated with non-Hodgkin lymphoma
Gabrielle Bradshaw et al.
META GENE (2015)
TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
Maria Hernandez-Sanchez et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma
Fazila Asmar et al.
HAEMATOLOGICA (2013)
Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma
S. Caramuta et al.
BLOOD CANCER JOURNAL (2013)
Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma
Cheng Fang et al.
ANNALS OF HEMATOLOGY (2012)
Comparison of genomic DNA extraction techniques from whole blood samples: a time, cost and quality evaluation study
Diego Chacon-Cortes et al.
MOLECULAR BIOLOGY REPORTS (2012)
DNA methylation and microRNA dysregulation in cancer
Hiromu Suzuki et al.
MOLECULAR ONCOLOGY (2012)
The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
E. Rao et al.
LEUKEMIA (2012)
MicroRNA signatures in B-cell lymphomas
L. Di Lisio et al.
BLOOD CANCER JOURNAL (2012)
DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
Rita Lok-Hay Yim et al.
Frontiers in Genetics (2012)
The miR-17-92 MicroRNA Cluster Is Regulated by Multiple Mechanisms in B-Cell Malignancies
Ming Ji et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale
D. J. P. M. Stumpel et al.
LEUKEMIA (2011)
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines
Rachel E. Culpin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K. Ghosh et al.
BLOOD (2009)
Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma
Charles H. Lawrie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
Changchun Xiao et al.
NATURE IMMUNOLOGY (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Methylation of human microRNA genes in normal and neoplastic cells
Barbara Weber et al.
CELL CYCLE (2007)
DNA methylation analysis by pyrosequencing
Joeg Tost et al.
NATURE PROTOCOLS (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing
JD Gruber et al.
HUMAN GENETICS (2002)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
